Skip to main content

CorMedix Inc.

CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001410098

No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding CorMedix Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of CRMD: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders92101+9
Shares17.9M18.7M+850.8K (+4.8%)
Value$66.2M$70.5M+$4.26M (+6.4%)

New holders (17)

Institutions that held CorMedix Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to CRMD in Q4 2023
InstitutionSharesValue% of portfolio
Anson Funds Management LP199,000$748.2K0.15%
Squarepoint Ops LLC77,066$289.8K0.00%
Jump Financial, LLC70,685$265.8K0.01%
Man Group plc35,000$131.6K0.00%
SG Americas Securities, LLC28,465$107.0K0.00%
Virtu Financial LLC27,379$103.0K0.01%
MJP Associates Inc25,000$94.0K0.03%
Gsa Capital Partners LLP24,721$93.0K0.01%
Beacon Pointe Advisors, LLC24,000$90.2K0.00%
Two Sigma Securities, LLC22,244$83.6K0.00%
Wolverine Trading, LLC16,101$60.5K0.00%
Cetera Advisor Networks LLC12,152$45.7K0.00%
Bayesian Capital Management, LP10,519$39.6K0.00%
GWM Advisors LLC500$1.88K0.00%
Allworth Financial LP140$5270.00%
Farther Finance Advisors, LLC106$3990.00%
The PNC Financial Services Group, Inc.18$680.00%

Sold out (8)

Institutions that held CorMedix Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of CRMD in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Alyeska Investment Group, L.P.150,000$555.0K
Occudo Quantitative Strategies LP74,763$276.6K
Two Sigma Advisers, LP51,900$192.0K
Verition Fund Management LLC21,000$77.7K
XTX Topco Ltd15,412$57.0K
Centiva Capital, LP13,046$48.3K
Ameriprise Financial Inc10,700$39.6K
Massmutual Trust Co FSB250$925